KBC Group NV Raises Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

KBC Group NV lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 16.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,013 shares of the company’s stock after purchasing an additional 700 shares during the quarter. KBC Group NV’s holdings in Option Care Health were worth $157,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Blue Trust Inc. lifted its holdings in Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after buying an additional 377 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares during the period. Trust Point Inc. grew its stake in Option Care Health by 2.6% in the third quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock worth $755,000 after purchasing an additional 622 shares in the last quarter. Nisa Investment Advisors LLC increased its holdings in Option Care Health by 5.4% during the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock worth $376,000 after purchasing an additional 690 shares during the period. Finally, State of Alaska Department of Revenue raised its position in Option Care Health by 3.8% during the 3rd quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company’s stock valued at $621,000 after purchasing an additional 735 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $21.88 on Thursday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The stock has a market capitalization of $3.72 billion, a price-to-earnings ratio of 18.39, a PEG ratio of 2.27 and a beta of 1.32. The firm’s 50 day simple moving average is $27.98 and its 200-day simple moving average is $29.21. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63.

Wall Street Analysts Forecast Growth

A number of research firms have commented on OPCH. Barrington Research cut their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Truist Financial cut their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Finally, Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average target price of $30.83.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction on Friday, November 8th. The stock was acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.64% of the stock is owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.